Work

The effect of complement factor H Y402H polymorphism on visual outcomes after anti-VEGF treatment of exudative AMD

Year: 2018
Type: article
Study design: Observational Study
Abstract: Purpose: The Y402H complement factor H single nucleotide polymorphism (SNP) is associated with an increase in incidence of age-related macular degeneration (AMD).However, it is not well understood if this pro-inflammatory risk factor affects visual acuity outcomes after treatment with anti-vascular endothelial growth factor (VEGF).The purpose of this study was to assess the relationships among Y402H status, visual acuity (VA), and anti-VEGF treatment outcomes.Methods: Patients with AMD receiving anti-VEGF injections were recruited from the retina service at The Ohio State University.Visual acuity was measured at the initiation of a series of anti-VEGF injections and one year later using a back-lit ETDRS chart with by-letter scoring.DNA was isolated from blood samples using Qiagen's DNeasy kit and SNP status determined with a custom TaqMan SNP genotyping assay.Regression analyses were used to assess the relationships between SNP status and outcomes.Results: Eighty-four patients (51.2% female) were enrolled with a mean ± SD age of 81 ± 9 years.Mean VA of the treated eye was 0.75 ± 0.47 logMAR at time of enrollment.Of our patients, 22.6% did not have Y402H risk factor, 51.2% were heterozygous, and 26.2% were homozygous.Visual acuity at baseline and one year was significantly iii associated with SNP status, with decreased VA for heterozygotes and a further reduction for homozygotes.Mean change in VA from baseline to one year for all subjects was 0.08 ± 0.23 logMAR.Y402H status was not associated with change in VA at one year.Conclusions: The presence of Y402H was associated with poorer VA at baseline and one year.The lack of apparent association of Y402H status with change in VA with treatment may be due to differences in factors such as AMD stage and previous treatments at time of the baseline visit.Further work will investigate the role of these factors in addition to Y402H status in determining treatment outcomes.
Author: Chakuroff, Carolyn
Language: English
Subfield: Ophthalmology
Field: Medicine
Open Access status: green
OpenAlex ID: W7018796100
FWCI:
Cites: 93
Cited by:
Related to: 10